Low bitter taste levodropropizine oral solution

A technology of levopromazine and oral solution, applied in the field of medicine, can solve the problems of high degree of pain, limited effect of liquid oral solution, etc., and achieve the effects of reducing bitterness and prolonging action time.

Inactive Publication Date: 2018-12-14
ZHEJIANG SHENGBOKANG PHARMA CO LTD
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The present invention aims to overcome the relatively strong bitterness of levodropropizine in the prior art, and the high degree of suffering of patients during use. The existing method for reducing bitterness is effective for solid

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0033] Example 1

[0034] A low-bitter levopiperazine oral solution, which contains:

[0035] Main medicine: Cyclodextrin-embedded levopiperazine 2g;

[0036] Accessories: 30g / L citric acid aqueous solution 3~4g;

[0037] Accessories: sucrose 345.g;

[0038] Accessories: orange flavor 0.1g;

[0039] Excipients: methyl paraben 0.25g;

[0040] Excipients: propyl paraben 0.15;

[0041] Accessories: 30% ethanol water 10ml;

[0042] Diluent: purified water to 1000ml

[0043] The pH regulator adjusts the pH value of the levoxipropiazine oral solution to 5.6. .

[0044] The preparation method of the cyclodextrin-embedded levopiperazine is as follows:

[0045] (1) Preparation of Levopropiperazine Dispersion: Weigh 10 parts of Levopropiperazine, 10 parts of β-cyclodextrin, 1 part of gum arabic and 50 parts of water in parts by weight, and stir it evenly with 800W power Ultrasound for 0.5 hours to obtain a dispersion of levopiprazine;

[0046] (2) Homogenization: The levoxipropiperazine dispersion obtai

Example Embodiment

[0048] Example 2

[0049] A low-bitter levopiperazine oral solution, which contains:

[0050] Main medicine: Cyclodextrin-embedded levoxipropiperazine 8g;

[0051] Accessories: 50g / L lactic acid aqueous solution 4g;

[0052] Accessories: sucrose 360g;

[0053] Accessories: grape flavor 0.5g;

[0054] Excipients: methyl paraben 0.31g;

[0055] Excipients: propyl paraben 0.19g;

[0056] Accessories: 60% ethanol water 5ml;

[0057] Diluent: purified water to 1000ml

[0058] The pH regulator adjusts the pH value of the levoxiprozine oral solution to 6.8.

[0059] The preparation method of the cyclodextrin-embedded levopiperazine is as follows:

[0060] (1) Preparation of Levopropiperazine Dispersion: Weigh 20 parts of Levopropiperazine, 20 parts of β-cyclodextrin, 3 parts of Gum Arabic and 50 parts of water in parts by weight, and stir it evenly with 800W power Ultrasound for 0.5 hours to obtain a dispersion of levopiprazine;

[0061] (2) Homogenization: Place the levoxipropiperazine dispersion obt

Example Embodiment

[0063] Example 3

[0064] A low-bitter levopiperazine oral solution, which contains:

[0065] Main medicine: Cyclodextrin-encapsulated levoxipropiperazine 6g;

[0066] Excipients: 40g / L tartaric acid 3.5g;

[0067] Accessories: 350g of sucrose;

[0068] Accessories: Apple flavor 0.3g;

[0069] Excipients: methyl paraben 0.22g;

[0070] Excipients: 0.13g of propyl paraben;

[0071] Accessories: 50% ethanol water 8ml;

[0072] Diluent: add purified water to 1000ml;

[0073] The pH regulator adjusts the pH of the levoxipropiperazine oral solution to 5.9.

[0074] The preparation method of the cyclodextrin-embedded levopiperazine is as follows:

[0075] (1) Preparation of Levopropiperazine Dispersion: Weigh 15 parts of Levopropiperazine, 15 parts of β-cyclodextrin, 2 parts of gum arabic and 50 parts of water in parts by weight, and stir it to 800W power. Ultrasound for 0.5 hours to obtain a dispersion of levopiprazine;

[0076] (2) Homogenization: the levoxipropiperazine dispersion obtained in step

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention relates to the field of medicine and particularly relates to a low bitter taste levodropropizine oral solution. Each 1000 ml of the levodropropizine oral solution contains: 2-8g of cyclodextrin embedded levodropropizine as a main drug, 3-4g of a pH regulator as an adjuvant, 345-360.5g of a compound flavoring agent as an adjuvant, 0.35-0.5g of a compound preservative as an adjuvant, 5-10ml of ethanol as an adjuvant and the balance of purified water as a diluent. The low bitter taste levodropropizine oral solution solves the problem that the existing levodropropizine has a thick bitter taste bringing pain to a patient in use. The existing bitter taste reducing method is effective for solid tablets and has limited effects on the oral liquid. The low bitter taste levodropropizineoral solution can effectively reduce the bitter taste of levodropropizine, can be effectively applied to the oral liquid, can also produce a sustained release effect and can prolong the action of drugs.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner ZHEJIANG SHENGBOKANG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products